Technology Offerings

Immunotherapy Breakthrough: PAX2 and PAX8 T-Cell Epitopes

Immunogenic T-cell epitopes from PAX2 and PAX8 have been found as promising immunotherapy against renal, colorectal, breast and ovarian cancer.

Further Information: PDF

ipal GmbH
Phone: +49 (0)30/2125-4820

Contact
Ursula Haufe

Comments (0)

Write a comment